Roche Holdings, Inc. Sustainability Profile
Roche Holdings, Inc., commonly referred to as Roche, is a leading global healthcare company headquartered in the United States. Founded in 1896, Roche has established a strong presence in the pharmaceutical and diagnostics industries, with significant operations across Europe, Asia, and the Americas. The company is renowned for its innovative approach to personalised medicine, focusing on oncology, immunology, and infectious diseases. Roche's core products include cutting-edge pharmaceuticals and advanced diagnostic tools, which are distinguished by their commitment to research and development. With a robust market position, Roche has achieved numerous milestones, including being a pioneer in biotechnology and maintaining a strong portfolio of blockbuster drugs. The company's dedication to improving patient outcomes solidifies its reputation as a leader in the healthcare sector.
DitchCarbon Score
How does Roche Holdings, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Roche Holdings, Inc.'s score of 37 is higher than 56% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Roche Holdings, Inc.'s reported carbon emissions
In 2022, Roche Holdings, Inc. reported total carbon emissions of approximately 74,260 kg CO2e, with Scope 1 emissions accounting for about 17,500 kg CO2e and Scope 3 emissions contributing approximately 56,760 kg CO2e, primarily from business travel. Notably, there were no reported Scope 2 emissions, indicating no purchased electricity emissions for that year. For 2023, Roche's CO2 intensity was reported at 500 kg CO2e per employee for Scope 1 and 2 emissions, while in 2025, the company indicated a significantly lower CO2 intensity of about 0.4 kg CO2e per employee, reflecting a commitment to reducing its carbon footprint. Roche Holdings, Inc. is a current subsidiary of Roche Holding AG, which influences its climate commitments and emissions reporting. However, there are currently no specific reduction targets or initiatives disclosed under the Science Based Targets initiative (SBTi) or other climate pledges. The company continues to focus on its carbon reduction strategies, as outlined in its Carbon Reduction Plan for the UK and Ireland, but specific targets have not been established.
How Carbon Intensive is Roche Holdings, Inc.'s Industry?
How Carbon Intensive is Roche Holdings, Inc.'s Location?
Roche Holdings, Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Roche Holdings, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
